Venture Visionary Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Venture Visionary Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,385	Closed	-$239K	–	707
2025 Q3	$239K	Sell	2,385 -300	-11%	-$27K	0.01%	551
2025 Q2	$223K	Buy	2,685 +50	+2%	+$3.99K	0.01%	540
2025 Q1	$214K	Sell	2,635 -10	-0.4%	-$894	0.01%	524
2024 Q4	$238K	Sell	2,645 -271	-9%	-$26.3K	0.01%	495
2024 Q3	$288K	Buy	2,916 +1	+0%	+$98	0.01%	464
2024 Q2	$270K	Sell	2,915 -2,425	-45%	-$217K	0.01%	473
2024 Q1	$507K	Buy	+5,340	New	+$496K	0.02%	375
2022 Q3	–	Sell	-1,308	Closed	-$97.1K	–	1567
2022 Q2	$97.1K	Buy	+1,308	New	+$98.2K	0.01%	614
2021 Q4	–	Sell	-8,475	Closed	-$1.06M	–	537
2021 Q3	$1.06M	Buy	+8,475	New	+$1.09M	0.08%	211

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Venture Visionary Partners's XBI Position: Q4 2025 in Review

Venture Visionary Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 2,385 shares — an estimated $239K sold.

Venture Visionary Partners first reported a position in XBI in Q3 2021 and held it in 9 quarters. The position peaked at $1.06M in Q3 2021. 814 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

Venture Visionary Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
Venture Visionary Partners sold 2,385 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $239K.
Venture Visionary Partners first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and held it in 9 quarters.
Venture Visionary Partners's State Street SPDR S&P Biotech ETF position peaked at $1.06M in Q3 2021.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Venture Visionary Partners's 13F filing for Q4 2025, filed 13 Feb 2026.